Incentives, Institutional Backing, and COVID-19 Vaccination Uptake in Burkina Faso

How to cite

Wengström, Erik; Campos-Mercade, Pol; Sepahvand, Mohammad; Schneider, Florian. 2026. "Incentives, Institutional Backing, and COVID-19 Vaccination Uptake in Burkina Faso." AEA RCT Registry. AEARCTR-0017403. https://doi.org/10.1257/rct.17403-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Erik Wengström* , Pol Campos-Mercade , Mohammad Sepahvand , Florian Schneider

* Primary investigator

Registry ID
AEARCTR-0017403
DOI
https://doi.org/10.1257/rct.17403-1.0
First registered
Last updated
Status
In development
Trial dates
2026-04-15 – 2027-12-31
Countries
Private
JEL codes
I12, I18, C93
Registry record
http://www.socialscienceregistry.org/trials/17403

Abstract

This study investigates how financial incentives and perceived alignment with the source offering them affect COVID-19 vaccination uptake in Burkina Faso. We run a large-scale individual-level randomized controlled trial in which adults receive a vaccination message backed either by the Ministry of Health or by Western researchers, combined with no incentive, a low incentive (2000 CFA), or a high incentive (15000 CFA). The baseline survey measures perceived alignment with each source, perceived expertise, vaccine beliefs and intentions. The primary outcome is verified vaccination uptake within 30 days, measured using administrative records. The design allows us to estimate the causal effect of incentives and to test whether their effectiveness varies with the source presenting them. Secondary analyses examine effects on stated intentions and vaccine skepticism, as well as heterogeneity linked to baseline perceived alignment and vaccine attitudes.

Intervention

We conduct a randomized controlled trial in Burkina Faso to evaluate the effectiveness of financial incentives and information messaging on COVID-19 vaccination uptake. Individuals who have not received a COVID-19 vaccine in the past six months are randomly assigned to receive one of several information messages encouraging vaccination. Information messages vary in (i) whether they include no incentive, a low incentive, or a high incentive for getting vaccinated within 30 days, and (ii) whether the message is presented as coming from the Ministry of Health or from Western researchers. Participants are then followed using administrative vaccination records to measure vaccine uptake within one month.

Experimental design

We conduct a randomized controlled trial in Burkina Faso to evaluate the effectiveness of financial incentives and information messaging on COVID-19 vaccination uptake. Individuals who have not received a COVID-19 vaccine in the past six months are randomly assigned to receive one of several information messages encouraging vaccination. Information messages vary in (i) whether they include no incentive, a low incentive, or a high incentive for getting vaccinated within 30 days, and (ii) whether the message is presented as coming from the Ministry of Health or from Western researchers. Participants are then followed using administrative vaccination records to measure vaccine uptake within one month.

Design details

Randomization method
Randomization done in office by a computer: computer-generated simple random assignment into six arms with equal probability.
Randomization unit
Unit of randomization: individual.
Clusters
Randomization is conducted at the individual level. The study is not cluster randomized. We sample approximately 22 500 individuals across 9 regions (regional capitals). These regions serve as sampling strata rather than cluster-randomized units.
Observations
22 500 individuals
Arms
Six treatment arms and we will implement equal allocation by arm, so: 3 750 individuals per treatment arm. Intended total sample = 22 500 (6 arms × 3 750).
Primary outcomes
The primary outcome of interest is COVID-19 vaccination uptake, measured using administrative vaccination records. For each participant, we observe whether they received a dose of a COVID-19 vaccine within 30 days after receiving the intervention. The primary outcome is therefore a binary indicator equal to 1 if the participant is recorded as having obtained a vaccine dose within the 30-day window, and 0 otherwise. This measure is not self-reported and is obtained from national administrative data.
Secondary outcomes
We have two secondary outcomes: 1. Vaccination intention (binary): After receiving the intervention, participants are asked whether they plan to take a dose of a COVID-19 vaccine within 30 days of participating in this survey (Yes/No)? 2. Vaccine skepticism (index): An index capturing beliefs about vaccine safety and efficacy. This measure reflects overall skepticism toward COVID-19 vaccination.

Cited by

No citation data available for this registration yet.

Keywords